Literature DB >> 32511469

Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in France.

Nicolas Hoertel1,2, Martin Blachier3, Carlos Blanco4, Mark Olfson5, Marc Massetti3, Marina Sánchez Rico1,6, Frédéric Limosin1,2, Henri Leleu3.   

Abstract

Most European countries have responded to the COVID-19 threat by nationwide implementation of barrier measures and lockdown. However, assuming that population immunity will build up through the epidemic, it is likely to rebound once these measures are relaxed, possibly leading to a second or multiple repeated lockdowns. In this report, we present results of epidemiological modelling that has helped inform policy making in France. We used a stochastic agent-based microsimulation model of the COVID-19 epidemic in France, and examined the potential impact of post-quarantine measures, including social distancing, mask-wearing, and shielding of the population the most vulnerable to severe COVID-19 infection, on the disease's cumulative incidence and mortality, and on ICU-bed occupancy. The model calibrated well and variation of model parameter values had little impact on outcome estimates. While quarantine is effective in containing the viral spread, it would be unlikely to prevent a rebound of the epidemic once lifted, regardless of its duration. Both social distancing and mask-wearing, although effective in slowing the epidemic and in reducing mortality, would also be ineffective in ultimately preventing the overwhelming of ICUs and a second lockdown. However, these measures coupled with shielding of vulnerable people would be associated with better outcomes, including lower cumulative incidence, mortality, and maintaining an adequate number of ICU beds to prevent a second lockdown. Benefits would nonetheless be markedly reduced if these measures were not applied by most people or not maintained for a sufficiently long period, as herd immunity progressively establishes in the less vulnerable population.

Entities:  

Keywords:  ABM; COVID-19; France; ICU-bed occupancy; SARS-CoV-2; incidence; lifting; lockdown; mortality; quarantine

Year:  2020        PMID: 32511469      PMCID: PMC7255789          DOI: 10.1101/2020.04.30.20086264

Source DB:  PubMed          Journal:  medRxiv


  16 in total

Review 1.  Herd immunity and herd effect: new insights and definitions.

Authors:  T J John; R Samuel
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Special report: The simulations driving the world's response to COVID-19.

Authors:  David Adam
Journal:  Nature       Date:  2020-04       Impact factor: 49.962

3.  Predictive Mathematical Models of the COVID-19 Pandemic: Underlying Principles and Value of Projections.

Authors:  Nicholas P Jewell; Joseph A Lewnard; Britta L Jewell
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

Review 4.  Face masks to prevent transmission of influenza virus: a systematic review.

Authors:  B J Cowling; Y Zhou; D K M Ip; G M Leung; A E Aiello
Journal:  Epidemiol Infect       Date:  2010-01-22       Impact factor: 2.451

5.  Simplicial models of social contagion.

Authors:  Iacopo Iacopini; Giovanni Petri; Alain Barrat; Vito Latora
Journal:  Nat Commun       Date:  2019-06-06       Impact factor: 14.919

6.  How will country-based mitigation measures influence the course of the COVID-19 epidemic?

Authors:  Roy M Anderson; Hans Heesterbeek; Don Klinkenberg; T Déirdre Hollingsworth
Journal:  Lancet       Date:  2020-03-09       Impact factor: 79.321

7.  Face mask use and control of respiratory virus transmission in households.

Authors:  C Raina MacIntyre; Simon Cauchemez; Dominic E Dwyer; Holly Seale; Pamela Cheung; Gary Browne; Michael Fasher; James Wood; Zhanhai Gao; Robert Booy; Neil Ferguson
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

8.  COVID-19 and smoking: A systematic review of the evidence.

Authors:  Constantine I Vardavas; Katerina Nikitara
Journal:  Tob Induc Dis       Date:  2020-03-20       Impact factor: 2.600

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

Review 10.  The psychological impact of quarantine and how to reduce it: rapid review of the evidence.

Authors:  Samantha K Brooks; Rebecca K Webster; Louise E Smith; Lisa Woodland; Simon Wessely; Neil Greenberg; Gideon James Rubin
Journal:  Lancet       Date:  2020-02-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.